» Articles » PMID: 21221591

Macrophage Activation Syndrome in Children with Systemic Onset Juvenile Idiopathic Arthritis: Clinical Experience from Northwest India

Overview
Journal Rheumatol Int
Specialty Rheumatology
Date 2011 Jan 12
PMID 21221591
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study is to describe the clinical and laboratory features of macrophage activation syndrome (MAS) in systemic onset juvenile idiopathic arthritis (SOJIA) at a tertiary care center in northwest India. Review of medical records of all children with SOJIA admitted during the period January 1995-December 2008 in Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, was done. Six patients (5 boys and 1 girl) with SOJIA and MAS were identified. Mean age at time of disease onset was 6.5 years. MAS was the presenting manifestation of SOJIA in 4 patients. Clinical manifestations included fever (6/6), clinical shock (6/6), encephalopathy (5/6), generalized lymphadenopathy (4/6), hepatosplenomegaly (3/6), jaundice and abdominal tenderness (3/6), cardiac involvement (3/6), and meningeal irritation (2/6). Laboratory findings at onset of MAS included decreasing total leukocyte and platelet counts, coagulopathy, elevated transaminases, hyponatremia, and lipid abnormalities. Hemophagocytosis was demonstrable in the bone marrow in 4 patients and in the lymph node in 1. For treatment, we used intravenous methylprednisolone (4/6), oral prednisolone (2/6), and intravenous immunoglobulin (2/6). Outcome was favorable in all patients except one who died of rapidly progressive disease. This paper describes the experience of JIA-related macrophage activation syndrome in a tertiary Indian center. We have shown that MAS can be the early presenting manifestation of evolving SOJIA. Early diagnosis and aggressive management can have a significant impact on the mortality associated with this syndrome. We stress on the role of glucocorticoids in the management of this condition and believe that glucocorticoids have a far more important role in the management of this condition than what has been previously reported.

Citing Articles

Other Immunomodulatory Treatment for Cytokine Storm Syndromes.

Batu E, Ozen S Adv Exp Med Biol. 2024; 1448:601-609.

PMID: 39117842 DOI: 10.1007/978-3-031-59815-9_40.


Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project.

Baldo F, Erkens R, Mizuta M, Rogani G, Lucioni F, Bracaglia C Rheumatology (Oxford). 2024; 64(1):32-44.

PMID: 39058514 PMC: 11701305. DOI: 10.1093/rheumatology/keae391.


Paediatric haemophagocytic lymphohistiocytosis: clinical presentation and outcome of 20 patients at a single institution.

Dahman H, Aljabry A Sudan J Paediatr. 2024; 23(2):199-213.

PMID: 38380413 PMC: 10876277. DOI: 10.24911/SJP.106-1659160002.


Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis.

Ghoraba H, Matsumiya W, Khojasteh H, Akhavanrezayat A, Karaca I, Or C Clin Ophthalmol. 2022; 16:1697-1706.

PMID: 35673349 PMC: 9167570. DOI: 10.2147/OPTH.S366370.


Macrophage Activation Syndrome in Children: Diagnosis and Management.

Bagri N, Gupta L, Sen E, Ramanan A Indian Pediatr. 2021; 58(12):1155-1161.

PMID: 33772536 PMC: 8732159.


References
1.
Ogawa E, Otaguro S, Murata M, Kainuma M, Sawayama Y, Furusyo N . Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection. J Infect Chemother. 2008; 14(5):377-82. DOI: 10.1007/s10156-008-0636-x. View

2.
Silva C, Silva C, Robazzi T, Lotito A, Junior A, Jacob C . [Macrophage activation syndrome associated with systemic juvenile idiopathic arthritis]. J Pediatr (Rio J). 2004; 80(6):517-22. View

3.
Tristano A, Casanova-Escalona L, Torres A, Rodriguez M . Macrophage activation syndrome in a patient with systemic onset rheumatoid arthritis: rescue with intravenous immunoglobulin therapy. J Clin Rheumatol. 2006; 9(4):253-8. DOI: 10.1097/01.rhu.0000081259.61370.eb. View

4.
Bleesing J, Prada A, Siegel D, Villanueva J, Olson J, Ilowite N . The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum. 2007; 56(3):965-71. DOI: 10.1002/art.22416. View

5.
Fame T, Engelhard D, RILEY Jr H . Hemophagocytosis accompanying typhoid fever. Pediatr Infect Dis. 1986; 5(3):367-9. DOI: 10.1097/00006454-198605000-00018. View